Alligator Bioscience AB

STU:7AL (Sweden)  
€ 0.07 (-2.61%) Apr 30
At Loss
P/B:
50.00
Market Cap:
€ 58.19M ($ 62.35M)
Enterprise V:
€ 53.92M ($ 57.78M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.
Name Current Vs Industry Vs History
Cash-To-Debt 4.11
Equity-to-Asset 0.1
Debt-to-Equity 1.36
Debt-to-EBITDA -0.07
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -15.62
Distress
Grey
Safe
Beneish M-Score -4.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.44
9-Day RSI 32.32
14-Day RSI 37.39
6-1 Month Momentum % 221.83
12-1 Month Momentum % 66.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.79
Quick Ratio 0.79
Cash Ratio 0.67
Days Sales Outstanding 53.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -69.9
Shareholder Yield % -28.36